Nebula Research & Development LLC Organon & Co. Transaction History
Nebula Research & Development LLC
- $1.17 Trillion
- Q2 2025
A detailed history of Nebula Research & Development LLC transactions in Organon & Co. stock. As of the latest transaction made, Nebula Research & Development LLC holds 75,774 shares of OGN stock, worth $803,204. This represents 0.06% of its overall portfolio holdings.
Number of Shares
75,774
Previous 34,822
117.6%
Holding current value
$803,204
Previous $519 Million
41.46%
% of portfolio
0.06%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding OGN
# of Institutions
794Shares Held
210MCall Options Held
2.74MPut Options Held
1.79M-
Black Rock Inc. New York, NY32.6MShares$345 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.3MShares$342 Million0.01% of portfolio
-
Massachusetts Financial Services CO Boston, MA10.2MShares$109 Million0.03% of portfolio
-
State Street Corp Boston, MA9.52MShares$101 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny9.09MShares$96.4 Million0.05% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $2.7B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...